Public Joint Stock Company RN-Western Siberia Logo

Public Joint Stock Company RN-Western Siberia

CHGZ.ME

(3.0)
Stock Price

90,00 RUB

1.4% ROA

1.42% ROE

26.31x PER

Market Cap.

1.044.084.600,00 RUB

99.95% DER

0% Yield

62.42% NPM

Public Joint Stock Company RN-Western Siberia Stock Analysis

Public Joint Stock Company RN-Western Siberia Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Public Joint Stock Company RN-Western Siberia Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.37x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

3 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

4 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

5 ROE

The stock's ROE falls within an average range (1.42%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

6 ROA

The stock's ROA (1.4%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

7 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

8 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (54), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

9 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

10 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

Public Joint Stock Company RN-Western Siberia Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Public Joint Stock Company RN-Western Siberia Technical Stock Analysis
# Analysis Recommendation

Public Joint Stock Company RN-Western Siberia Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Public Joint Stock Company RN-Western Siberia Revenue
Year Revenue Growth
2011 470.000
2012 454.000 -3.52%
2013 14.127.000 96.79%
2014 29.518.000 52.14%
2015 39.160.000 24.62%
2016 37.485.000 -4.47%
2017 39.589.000 5.31%
2018 41.659.000 4.97%
2019 56.040.000 25.66%
2020 56.260.000 0.39%
2021 63.578.000 11.51%
2023 7.060.000 -800.54%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Public Joint Stock Company RN-Western Siberia Research and Development Expenses
Year Research and Development Expenses Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 1 0%
2017 3 100%
2018 2 -200%
2019 1 0%
2020 0 0%
2021 1 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Public Joint Stock Company RN-Western Siberia General and Administrative Expenses
Year General and Administrative Expenses Growth
2011 5.307.000
2012 12.976.000 59.1%
2013 43.926.000 70.46%
2014 51.761.000 15.14%
2015 69.195.000 25.2%
2016 54.457.000 -27.06%
2017 69.953.000 22.15%
2018 81.568.000 14.24%
2019 78.931.000 -3.34%
2020 77.597.000 -1.72%
2021 55.412.000 -40.04%
2023 35.256.000 -57.17%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Public Joint Stock Company RN-Western Siberia EBITDA
Year EBITDA Growth
2011 112.239.000
2012 103.967.000 -7.96%
2013 81.130.000 -28.15%
2014 67.133.000 -20.85%
2015 114.927.000 41.59%
2016 175.199.000 34.4%
2017 134.093.000 -30.65%
2018 74.062.000 -81.06%
2019 69.591.000 -6.42%
2020 -76.984.000 190.4%
2021 -50.896.000 -51.26%
2023 -42.700.000 -19.19%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Public Joint Stock Company RN-Western Siberia Gross Profit
Year Gross Profit Growth
2011 470.000
2012 454.000 -3.52%
2013 7.205.000 93.7%
2014 1.527.000 -371.84%
2015 2.748.000 44.43%
2016 1.489.000 -84.55%
2017 1.413.000 -5.38%
2018 1.013.000 -39.49%
2019 215.000 -371.16%
2020 608.000 64.64%
2021 4.375.000 86.1%
2023 -6.744.000 164.87%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Public Joint Stock Company RN-Western Siberia Net Profit
Year Net Profit Growth
2011 90.354.000
2012 89.154.000 -1.35%
2013 64.326.000 -38.6%
2014 53.035.000 -21.29%
2015 91.613.000 42.11%
2016 187.555.000 51.15%
2017 107.180.000 -74.99%
2018 59.070.000 -81.45%
2019 55.000.000 -7.4%
2020 18.301.000 -200.53%
2021 39.683.000 53.88%
2023 -34.540.000 214.89%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Public Joint Stock Company RN-Western Siberia Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2011 3
2012 3 0%
2013 2 -50%
2014 2 -100%
2015 3 66.67%
2016 7 57.14%
2017 4 -75%
2018 2 -100%
2019 2 0%
2020 1 -100%
2021 1 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Public Joint Stock Company RN-Western Siberia Free Cashflow
Year Free Cashflow Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 -48.000 100%
2016 -46.573.000 99.9%
2017 -94.749.000 50.85%
2018 -94.875.000 0.13%
2019 0 0%
2019 -94.283 100%
2020 -80.309 -17.4%
2021 -70.254 -14.31%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Public Joint Stock Company RN-Western Siberia Operating Cashflow
Year Operating Cashflow Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 -46.237.000 100%
2017 -92.298.000 49.9%
2018 -93.642.000 1.44%
2019 0 0%
2019 -93.611 100%
2020 -79.857 -17.22%
2021 -70.254 -13.67%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Public Joint Stock Company RN-Western Siberia Capital Expenditure
Year Capital Expenditure Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 48.000 100%
2016 336.000 85.71%
2017 2.451.000 86.29%
2018 1.233.000 -98.78%
2019 0 0%
2019 672 100%
2020 452 -48.67%
2021 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Public Joint Stock Company RN-Western Siberia Equity
Year Equity Growth
2010 1.964.351.000
2011 2.054.705.000 4.4%
2012 2.143.859.000 4.16%
2013 2.208.185.000 2.91%
2014 2.261.220.000 2.35%
2015 2.352.833.000 3.89%
2016 2.539.918.000 7.37%
2017 2.646.881.000 4.04%
2018 2.705.778.000 2.18%
2019 843.695.000 -220.71%
2020 2.778.129.000 69.63%
2021 2.819.076.000 1.45%
2023 2.845.582.000 0.93%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Public Joint Stock Company RN-Western Siberia Assets
Year Assets Growth
2010 2.007.099.000
2011 2.059.963.000 2.57%
2012 2.146.039.000 4.01%
2013 2.219.194.000 3.3%
2014 2.279.233.000 2.63%
2015 2.376.226.000 4.08%
2016 2.562.719.000 7.28%
2017 2.670.521.000 4.04%
2018 2.732.304.000 2.26%
2019 2.788.990.000 2.03%
2020 2.807.385.000 0.66%
2021 2.843.066.000 1.26%
2023 2.858.405.000 0.54%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Public Joint Stock Company RN-Western Siberia Liabilities
Year Liabilities Growth
2010 42.748.000
2011 5.258.000 -713.01%
2012 2.180.000 -141.19%
2013 11.009.000 80.2%
2014 18.013.000 38.88%
2015 23.393.000 23%
2016 22.331.000 -4.76%
2017 22.953.000 2.71%
2018 25.666.000 10.57%
2019 27.352.000 6.16%
2020 27.446.000 0.34%
2021 23.444.000 -17.07%
2023 12.823.000 -82.83%

Public Joint Stock Company RN-Western Siberia Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2.37
Net Income per Share
1.48
Price to Earning Ratio
26.31x
Price To Sales Ratio
16.42x
POCF Ratio
-14861.58
PFCF Ratio
-14861.57
Price to Book Ratio
0.37
EV to Sales
16.41
EV Over EBITDA
-20.5
EV to Operating CashFlow
-14854.54
EV to FreeCashFlow
-14854.54
Earnings Yield
0.04
FreeCashFlow Yield
-0
Market Cap
1,04 Bil.
Enterprise Value
1,04 Bil.
Graham Number
59.27
Graham NetNet
29.25

Income Statement Metrics

Net Income per Share
1.48
Income Quality
-1.77
ROE
0.01
Return On Assets
0.01
Return On Capital Employed
-0.02
Net Income per EBT
0.79
EBT Per Ebit
-0.98
Ebit per Revenue
-0.8
Effective Tax Rate
0.21

Margins

Sales, General, & Administrative to Revenue
0.87
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.07
Operating Profit Margin
-0.8
Pretax Profit Margin
0.79
Net Profit Margin
0.62

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-0.01
Return on Tangible Assets
0.01
Days Sales Outstanding
6167.83
Days Payables Outstanding
28.39
Days of Inventory on Hand
0.94
Receivables Turnover
0.06
Payables Turnover
12.86
Inventory Turnover
386.95
Capex per Share
0

Balance Sheet

Cash per Share
0,02
Book Value per Share
105,32
Tangible Book Value per Share
105.32
Shareholders Equity per Share
105.32
Interest Debt per Share
105.27
Debt to Equity
1
Debt to Assets
0.99
Net Debt to EBITDA
0.01
Current Ratio
45.91
Tangible Asset Value
2,82 Bil.
Net Current Asset Value
1,05 Bil.
Invested Capital
1051844000
Working Capital
1,05 Bil.
Intangibles to Total Assets
0
Average Receivables
1,02 Bil.
Average Payables
0,00 Bil.
Average Inventory
220500
Debt to Market Cap
2.7

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Public Joint Stock Company RN-Western Siberia Dividends
Year Dividends Growth

Public Joint Stock Company RN-Western Siberia Profile

About Public Joint Stock Company RN-Western Siberia

Public Joint Stock Company RN-Western Siberia provides legal, libraries, and archiving services in Russia. The company was formerly known as Public Joint Stock Company Chernogorneft and changed its name to Public Joint Stock Company RN-Western Siberia in December 2016. The company was founded in 1992 and is based in Nizhnevartovsk, Russia. Public Joint Stock Company RN-Western Siberia is a subsidiary of Open Joint Stock Company RN Holding.

CEO
Ms. Buy Natalya Ivanovna
Employee
43
Address
Industrialnaya 107 bldg. 3
Nizhnevartovsk, 628609

Public Joint Stock Company RN-Western Siberia Executives & BODs

Public Joint Stock Company RN-Western Siberia Executives & BODs
# Name Age
1 Ms. T. G. Komarova
Chief Accountant
70
2 Ms. Buy Natalya Ivanovna
General Director & Director
70

Public Joint Stock Company RN-Western Siberia Competitors